The CEO of Germany's Merck ... an all-stock deal, according to a statement seen by Reuters. Biotech firm Recursion to buy smaller peer Exscientia for $688 million August 8, 2024 Merck KGaA is ...
In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target ...
Merck (MRK) stock was mangled today after the pharmaceutical and vaccine company released its guidance for 2025. The company expects adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback